RxDoctor Payments Data
★ My doctorsLook up a doctor →

Neil Sadick

Dermatology · New York, NYNPI 1841211422

Payments from drug & device makers

What this record shows

This record is dominated by grants: $340,167 of the $544,756 with a category attached, or 62.4%. Galderma Laboratories, L.p. accounts for 63.0% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $240,269 and has fallen 94.5% since, to $13,332 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$544,756in general payments, 2019–2025

Across 316 payments — averaging $1723.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$343K
  • AbbVie$150K
  • Lumenis BE Inc$14K
  • E.r. Squibb & Sons, L.L.C.$8K
  • Merz North America, Inc.$7K
  • LEO Pharma Inc.$7K
  • plus $16K from 26 others
$3,723,808in research payments, 2019–2025

Across 497 payments — averaging $7492.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$750K
  • Bausch Health US, LLC$475K
  • Eli Lilly$383K
  • Takeda Pharmaceuticals U.S.A., Inc.$363K
  • Merz North America, Inc.$323K
  • Incyte Corporation$300K
  • plus $1.1M from 17 others

What the payments were for

  • Consulting fees$165,75830%
  • Grants$340,16762%
  • Travel & lodging$13,3942%
  • Food & beverage$24,9195%
  • Education$5180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.28$343,332
AbbVie(2 entities)125$149,730
Lumenis BE Inc2$13,902
E.r. Squibb & Sons, L.L.C.18$7,902
Merz North America, Inc.26$7,424
LEO Pharma Inc.13$6,735
Ortho Dermatologics, A Division Of Bausch Health US, LLC15$6,057
Takeda Pharmaceuticals U.S.A., Inc.2$3,805
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$1,400
Endo Pharmaceuticals Inc.4$509
Johnson & Johnson10$428
Avita Medical Americas, LLC2$428
Novartis9$405
Almirall LLC6$339
Pfizer7$246
UCB, Inc.4$245
Amgen5$235
Lilly USA, LLC8$219
Incyte Corporation6$213
Biofrontera Inc.4$212
Solta Medical, A Division Of Bausch Health US, LLC2$199
Janssen Research & Development, LLC1$137
Sun Pharmaceutical Industries Inc.5$135
Bausch Health US, LLC1$121
Acelrx Pharmaceuticals, Inc.1$110
Regeneron Healthcare Solutions, Inc.2$61
Stemline Therapeutics Inc.1$57
Dermira, Inc.2$56
Sanofi1$37
Bristol Myers Squibb2$36
Journey Medical Corporation1$24
Sandoz1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$544,756 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Minoxidil39$528
Dutasteride15$413

Paid to pharmacies, not to this prescriber.

Other dermatology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →